Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,528,999
+$632,468 QoQ
Shares Held
14,024
+5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.70%
of 13F equity value
Holder Rank
#1,537
of 4,153 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VIAWEALTH, LLC holds $8,441,332 across 7 Drug Manufacturers - General names. ABBV ranks #1 (41.8% of the industry book) .
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,528,999 | 14,024 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,896,531 | 13,318 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,035,261 | 13,284 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,245,727 | 14,018 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,562,298 | 13,804 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,026,935 | 14,447 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,621,252 | 14,751 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,922,506 | 14,799 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,529,062 | 14,745 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,552,495 | 14,017 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,143,854 | 13,834 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,968,486 | 13,206 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,554,110 | 11,535 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,814,108 | 11,383 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,837,020 | 11,367 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||